| Disease ID | Disease name | Reference |
|---|
| MESH:D000230 |
Adenocarcinoma |
PMID:193073; PMID:2145045; PMID:2151368; PMID:2523869; PMID:2947675; PMID:31505237; PMID:3522997 |
| MESH:D000236 |
Adenoma |
PMID:8751273 |
| MESH:D000303 |
Adrenal Cortex Diseases |
PMID:8751273 |
| MESH:D000568 |
Amenorrhea |
PMID:3159786; PMID:6461984 |
| MESH:D001259 |
Ataxia |
PMID:6123383 |
| MESH:D001284 |
Atrophy |
PMID:8751273 |
| MESH:D001523 |
Mental Disorders |
PMID:6123383 |
| MESH:D001943 |
Breast Neoplasms |
PMID:6461984 |
| MESH:D002318 |
Cardiovascular Diseases |
PMID:2935644; PMID:2942707 |
| MESH:D002769 |
Cholelithiasis |
PMID:1385654 |
| MESH:D002972 |
Cleft Palate |
PMID:6461082 |
| MESH:D003072 |
Cognition Disorders |
PMID:12771113 |
| MESH:D003327 |
Coronary Disease |
PMID:10593314; PMID:12904517 |
| MESH:D003480 |
Cushing Syndrome |
PMID:8522428 |
| MESH:D003638 |
Deafness |
PMID:5550609 |
| MESH:D003704 |
Dementia |
PMID:12771112 |
| MESH:D003866 |
Depressive Disorder |
PMID:6123383 |
| MESH:D004487 |
Edema |
PMID:2935644 |
| MESH:D004714 |
Endometrial Hyperplasia |
PMID:2826865 |
| MESH:D005076 |
Exanthema |
PMID:6123383 |
| MESH:D005221 |
Fatigue |
PMID:6123383 |
| MESH:D005234 |
Fatty Liver |
PMID:1465320 |
| MESH:D005327 |
Fetal Resorption |
PMID:6461082 |
| MESH:D005831 |
Genital Diseases, Female |
PMID:2934853 |
| MESH:D005832 |
Genital Diseases, Male |
PMID:2934853 |
| MESH:D006331 |
Heart Diseases |
PMID:12904517; PMID:15070921 |
| MESH:D006345 |
Heart Septal Defects, Ventricular |
PMID:2934853 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
PMID:2145045; PMID:2151368; PMID:2523869; PMID:2826865; PMID:2947675; PMID:8123867 |
| MESH:D008579 |
Meningioma |
PMID:17586005 |
| MESH:D008595 |
Menorrhagia |
PMID:6461984 |
| MESH:D008599 |
Menstruation Disturbances |
PMID:17982332 |
| MESH:D009120 |
Muscle Cramp |
PMID:86447 |
| MESH:D009203 |
Myocardial Infarction |
PMID:12904517 |
| MESH:D009839 |
Oligomenorrhea |
PMID:6461984 |
| MESH:D010146 |
Pain |
PMID:3743595; PMID:6305660 |
| MESH:D010211 |
Papilledema |
PMID:2975585 |
| MESH:D011559 |
Pseudotumor Cerebri |
PMID:6454568 |
| MESH:D011655 |
Pulmonary Embolism |
PMID:1388285 |
| MESH:D013927 |
Thrombosis |
PMID:11253269; PMID:2531993 |
| MESH:D014012 |
Tinnitus |
PMID:5550609 |
| MESH:D014202 |
Tremor |
PMID:86447 |
| MESH:D014570 |
Urologic Diseases |
PMID:6461082 |
| MESH:D014715 |
Vertebrobasilar Insufficiency |
PMID:5550609 |
| MESH:D014717 |
Vertigo |
PMID:5550609 |
| MESH:D014839 |
Vomiting |
PMID:5550609 |
| MESH:D015430 |
Weight Gain |
PMID:123269; PMID:17982332 |
| MESH:D015619 |
Respiratory System Abnormalities |
PMID:6461082 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
PMID:31505237; PMID:8751273 |
| MESH:D016889 |
Endometrial Neoplasms |
PMID:193073; PMID:2826865; PMID:2947675 |
| MESH:D017514 |
Pityriasis Lichenoides |
PMID:4692137 |
| MESH:D018269 |
Carcinoma, Endometrioid |
PMID:6920328 |
| MESH:D018270 |
Carcinoma, Ductal, Breast |
PMID:8123867 |
| MESH:D018487 |
Ventricular Dysfunction, Left |
PMID:21670166 |
| MESH:D019964 |
Mood Disorders |
PMID:12727949 |
| MESH:D020246 |
Venous Thrombosis |
PMID:1388285 |
| MESH:D020521 |
Stroke |
PMID:11253269; PMID:12771114 |
| MESH:D020766 |
Intracranial Embolism |
PMID:11422601 |
| MESH:D041781 |
Jaundice, Obstructive |
PMID:23956101 |
| MESH:D044584 |
Carcinoma, Ductal |
PMID:2826865 |
| MESH:D056486 |
Chemical and Drug Induced Liver Injury |
PMID:8751273 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.